The purpose of this study is to determine in hospitalized infants and children who are infected with respiratory syncytial virus (RSV) the dose-response relationship of multiple regimens of lumicitabine on antiviral activity based on nasal RSV shedding using quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR).
A Prospective Study to Assess the Pediatric Respiratory Syncytial Virus (RSV) Electronic Severity and Outcome Rating System (PRESORS) and Clinical Endpoints in Neonates, Infants, and Children ?36 Months of Age Hospitalized with RSV Infection
725-16Principal Investigator: Conducted at:
Miller Children's & Women's Hospital Long BeachCurrently enrolling additional patients:
up to 36 MonthsGender:
Male & Female